Johnson & Johnson has reinvented itself several times in recent years. In 2021, it was best known as the developer of a Covid ...
Q1 2026 earnings call recap: sales beat, raised guidance, ICOTYDE/INLEXZO launch metrics, and key risks—read now.
Good morning, and welcome to Johnson & Johnson's First Quarter 2026 Earnings Conference Call. [Operator Instructions] This call is being recorded. [Operator Instructions] I will now turn the call over ...
Johnson & Johnson JNJ reported 9.9% sales growth and adjusted earnings per share down 2.5% in the first quarter. Management ...
Streamsong’s upcoming Bone Valley has all the makings of the resort’s next great leap, adding David McLay Kidd’s vision to its one-of-a-kind vibe.
Johnson & Johnson JNJ reported first-quarter financial results on Tuesday. The transcript from the company’s first-quarter ...
Nissan calls it a “disruptive” new style. The all-electric Nissan Juke EV looks nothing like the gas-powered crossover and ...
Strong demand for cancer drug Darzalex and psoriasis treatment Tremfya more than offset a steep falloff in sales of its ...
Johnson & Johnson’s immunology bet is paying off as the drugmaker gears up to market an innovative new psoriasis pill and had ...
DNX, a five-issue comic book event series from writer Jed MacKay and artist Federico Vicentini, arrives this September and ...
Research by RIT assistant professor Benjamin Chin published in Science Advances may help determine which wavelengths helps ...
Andon Market, created and managed by an AI system, but staffed by two human employees, opened Friday in San Francisco.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results